April 19, 2018 09:48 AM EDT
Financing
AI

Biotech uni­corn's 'brain' at­tracts a $115M mega-round as in­vestors em­brace AI up­start

Amber Tong

Ar­ti­fi­cial in­tel­li­gence in drug de­vel­op­ment is still gain­ing mo­men­tum. Just ask Benev­o­len­tAI, which has brought in a new $115 mil­lion round for its tech­nol­o­gy that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Am­gen’s once-a-month obe­si­ty shot shows 20% weight loss af­ter a year

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

A service from the Financial Times